Literature DB >> 21139487

Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 years.

Cathia Soulie1, Sidonie Lambert-Niclot, Marc Wirden, Anne Simon, Marc-Antoine Valantin, Slim Fourati, Roland Tubiana, Christine Katlama, Vincent Calvez, Anne-Geneviève Marcelin.   

Abstract

The aim of this study was to analyse tropism evolution in HIV-1 patients with at least 2 years of viral load undetectability. For this purpose, HIV-1-infected antiretroviral-treated patients (n = 128) with a viral load less than 50 copies/ml for 4 years in median were studied. No change of virus tropism was observed in 92.9% of patients. Therefore, before the use of CCR5 antagonists, genotypic viral DNA tropism determination is an available tool.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21139487     DOI： 10.1097/QAD.0b013e32834345d3

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  8 in total

1.  HIV-1 coreceptor switch during 2 years of structured treatment interruptions.

Authors:  S Baroncelli; C M Galluzzo; M Andreotti; M F Pirillo; V Fragola; L E Weimer; M Giuliano; S Vella; L Palmisano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-04       Impact factor: 3.267

2.  Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppression.

Authors:  Russell E Baumann; Amy A Rogers; Hasnah B Hamdan; Harold Burger; Barbara Weiser; Wei Gao; Kathryn Anastos; Mary Young; William A Meyer; Rick L Pesano; Ron M Kagan
Journal:  AIDS Res Ther       Date:  2015-04-18       Impact factor: 2.250

3.  Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.

Authors:  Genny Meini; Barbara Rossetti; Claudia Bianco; Francesca Ceccherini-Silberstein; Simona Di Giambenedetto; Laura Sighinolfi; Laura Monno; Antonella Castagna; Gabriella Rozera; Antonella D'Arminio Monforte; Maurizio Zazzi; Andrea De Luca
Journal:  J Antimicrob Chemother       Date:  2013-10-23       Impact factor: 5.790

4.  Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapy.

Authors:  Guinevere Q Lee; Winnie Dong; Theresa Mo; David J H F Knapp; Chanson J Brumme; Conan K Woods; Steve Kanters; Benita Yip; P Richard Harrigan
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

5.  Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression.

Authors:  Antonella Castagna; Laura Monno; Stefania Carta; Laura Galli; Stefania Carrara; Valentina Fedele; Grazia Punzi; Iuri Fanti; Pietro Caramello; Alessandro Cozzi Lepri; Andrea De Luca; Francesca Ceccherini-Silberstein; Antonella d'Arminio Monforte
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection.

Authors:  Monica Basso; Daniela Zago; Renzo Scaggiante; Silvia Cavinato; Irene Pozzetto; Camilla Stagni; Beatrice Parisatto; Anna Maria Cattelan; Giuliana Battagin; Loredana Sarmati; Saverio Giuseppe Parisi
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

7.  HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.

Authors:  Christian Pou; Francisco M Codoñer; Alexander Thielen; Rocío Bellido; Susana Pérez-Álvarez; Cecilia Cabrera; Judith Dalmau; Marta Curriu; Yolanda Lie; Marc Noguera-Julian; Jordi Puig; Javier Martínez-Picado; Julià Blanco; Eoin Coakley; Martin Däumer; Bonaventura Clotet; Roger Paredes
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

8.  A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects.

Authors:  Saverio Giuseppe Parisi; Samantha Andreis; Carlo Mengoli; Renzo Scaggiante; Mario Cruciani; Roberto Ferretto; Vinicio Manfrin; Sandro Panese; Monica Basso; Caterina Boldrin; Stefania Bressan; Loredana Sarmati; Massimo Andreoni; Giorgio Palù
Journal:  BMC Infect Dis       Date:  2013-07-11       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.